Berkshire Fully Exits UnitedHealth Stake Amid Strong Recovery
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 54 minutes ago
0mins
Should l Buy UNH?
Source: stocktwits
- Berkshire's Exit Dynamics: Berkshire Hathaway sold its entire 5.04 million share position in UnitedHealth (UNH) during Q1, marking a significant shift in investment strategy under new CEO Greg Abel, even as the stock rebounded approximately 45% since February 10.
- Market Reaction Analysis: Despite Berkshire's exit prompting intense discussions among retail traders, many argued that the firm sold between $250 and $290, missing the opportunity for a strong rebound, reflecting ongoing concerns about Medicare reimbursement pressures.
- UnitedHealth's Strong Recovery: UNH closed at $270.59 at the end of Q1 and surged thereafter due to strong earnings and improved reimbursement rates, becoming one of the best-performing components in the Dow Jones Industrial Average, indicating optimistic market sentiment about its future prospects.
- AI Investment Strategy: UnitedHealth plans to invest $1.5 billion in AI in 2023, having already deployed over 1,000 AI use cases internally, which is expected to enhance operational efficiency and automation, positioning the company as a leader in the healthcare industry.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to fall
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 399.090
Low
330.00
Averages
397.82
High
444.00
Current: 399.090
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Berkshire's Exit Dynamics: Berkshire Hathaway sold its entire 5.04 million share position in UnitedHealth (UNH) during Q1, marking a significant shift in investment strategy under new CEO Greg Abel, even as the stock rebounded approximately 45% since February 10.
- Market Reaction Analysis: Despite Berkshire's exit prompting intense discussions among retail traders, many argued that the firm sold between $250 and $290, missing the opportunity for a strong rebound, reflecting ongoing concerns about Medicare reimbursement pressures.
- UnitedHealth's Strong Recovery: UNH closed at $270.59 at the end of Q1 and surged thereafter due to strong earnings and improved reimbursement rates, becoming one of the best-performing components in the Dow Jones Industrial Average, indicating optimistic market sentiment about its future prospects.
- AI Investment Strategy: UnitedHealth plans to invest $1.5 billion in AI in 2023, having already deployed over 1,000 AI use cases internally, which is expected to enhance operational efficiency and automation, positioning the company as a leader in the healthcare industry.
See More
- Quick Profit Exit: Berkshire Hathaway completely exited its 5 million-share position in UnitedHealth after the stock rebounded from $271 to $394 over nine months, locking in fast profits and showcasing its contrarian investment strategy during the stock's collapse in 2025.
- Positive Market Reaction: Following Berkshire's disclosure of its stake, the market reacted swiftly, with investors viewing it as a Buffett-style contrarian bet, despite UnitedHealth facing rising medical costs and ongoing DOJ investigations.
- New CEO's Strategic Shift: New CEO Greg Abel is reshaping the portfolio by reducing investments in healthcare insurers under regulatory scrutiny, indicating that UnitedHealth's rebound may have peaked and that downside risks are increasing.
- Strong Cash Flow Remains: Despite challenges, UnitedHealth remains the largest health insurer in the U.S., generating over $23 billion in operating cash flow over the past 12 months, underscoring its significant position and ongoing profitability in the industry.
See More
- Stable Apple Holdings: Berkshire maintained its stake in Apple at approximately 228 million shares, which, while below the historical peak of over 900 million shares, still represents 22% of its equity portfolio, reflecting confidence in Apple's long-term value.
- Significant Google Investment: Berkshire's share count in Alphabet surged from about 17.85 million to roughly 58 million, pushing the position's value to nearly $17 billion, indicating CEO Abel's strong confidence and willingness to invest in tech stocks.
- Exploration of New Investment Areas: The new $2.65 billion stake in Delta Air Lines and a minor position in Macy's signal Abel's readiness to enter sectors previously avoided by Buffett, further diversifying the investment portfolio.
- Aggressive Sell-offs: Berkshire exited positions in Amazon, Visa, Mastercard, and others, while slashing its stake in Constellation Brands by 95%, indicating Abel's intent to reshape the investment strategy and reinforce his personal style.
See More
- Portfolio Restructuring: Under Greg Abel's leadership, Berkshire Hathaway's equity portfolio underwent significant changes in the first three months, adding Delta Air Lines and Macy's, indicating a renewed focus on the airline and retail sectors.
- Massive Alphabet Stake Increase: Berkshire increased its stake in Google's parent company Alphabet by 224% in Q1, making it the company's seventh-largest holding with a market value of $16.6 billion, and the stock has rallied 38% since, showcasing the success of this decision.
- Reduction in Holdings: Abel dramatically cut the number of companies in the portfolio, selling off major stakes including Amazon and Visa, with Amazon's shares reduced from 10 million to 2.3 million, reflecting a significant strategic shift in investment focus.
- Return to Delta Airlines: Berkshire purchased 39.8 million shares of Delta Air Lines in Q1, currently valued at $2.8 billion, marking the company's first return to airline stocks since 2020, demonstrating confidence in the recovery of the airline industry.
See More
- Portfolio Restructuring: In Q1 2026, Berkshire Hathaway fully exited its position in UnitedHealth Group (UNH), marking the first portfolio shuffle under new CEO Greg Abel, indicating a strategic shift in the company's investment approach.
- Increased Google Holdings: Berkshire established a new $1 billion stake in Alphabet Class C shares (GOOG) and tripled its Class A shares (GOOGL) to approximately $15 billion, reflecting the company's continued confidence in tech stocks, which may drive long-term growth.
- New Investments and Reductions: The firm initiated a $2.6 billion position in Delta Air Lines (DAL) while trimming stakes in several core holdings, including Bank of America and Chevron, showcasing its confidence in the airline sector and caution towards traditional financial stocks.
- Positive Market Reaction: While shares of V, MA, and AMZN slipped marginally after hours, DAL and Macy's (M) saw increases of 3% and 6%, respectively, reflecting a positive market response to Berkshire's new investment strategy, particularly in the airline and retail sectors.
See More
- Delta Stake Acquisition: Berkshire Hathaway has acquired a stake in Delta Air Lines worth over $2.6 billion, making it the company's 14th largest holding, marking a return to the airline sector after exiting during the pandemic, indicating confidence in the industry's recovery.
- Portfolio Rebalancing: In the first quarter, Berkshire trimmed its stake in Chevron while significantly increasing its investment in Alphabet, now the seventh largest holding, reflecting a strategic shift towards technology stocks.
- Stock Sales: The conglomerate sold several stocks last quarter, including Mastercard and Visa, likely to unwind positions tied to departed investment manager Todd Combs, showcasing a strategic adjustment following management changes.
- Increased Cash Reserves: Buffett acknowledged the current investment environment is not ideal, with Berkshire's cash reserves nearing $400 billion, indicating challenges in finding suitable investment opportunities.
See More










